About Origio India Private Limited
Data last updated:
Origio India Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Origio A/S. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 03 August 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC155098. Its GSTIN is 27AACCT3478Q1ZK (Maharashtra). The company holds 15 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹1.49 Lakh. It was formerly known as Trivector Scientific Private Limited and Trivector Origio Scientific Private Limited. It is led by directors including Shipra Thukral and Amit Kumar Bhatnagar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 401 Delphi Hiranandani Business Park Powai Mumbai – 400076., Maharashtra, India – 400076.
As per the financials filed for FY 2025, the company reported a revenue of ₹213.52 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹8.65 Cr (net margin 4.1%) and EBITDA of ₹12.23 Cr (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 20% over five years.
The company has about 84 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: CooperSurgical. As per MCA filings, the company has satisfied charges of ₹4.5 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 2 cases are pending. The company has 7 deals on record (4 rights issues, 3 secondary share transfers); the latest was in October 2023. Its 6 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 3 smaller; the largest is Avana Medical Devices Private Limited with revenue of ₹223.27 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website coopersurgical.com.
Company details
Name history
Origio India has undergone 2 name changes throughout its history. The company was previously known as Trivector Scientific Private Limited, and Trivector Origio Scientific Private Limited. The current legal name is Origio India Private Limited.
| Company Name | Status |
|---|---|
| Origio India Private Limited | Current |
| Trivector Scientific Private Limited | Previous |
| Trivector Origio Scientific Private Limited | Previous |
Contact details
Origio India Private Limited's registered office is in Mumbai, Maharashtra. Its website is coopersurgical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressC – 401 Delphi Hiranandani Business Park Powai Mumbai – 400076., Maharashtra, India – 400076
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Origio India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Origio India operates one associated brand: CooperSurgical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers medical devices for fertility, contraception, and women's health care globally. | coopersurgical.com |
Business activity
The main business activity of Origio India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Origio India Private Limited, buy the company report.
Financials of Origio India Private Limited
FY 2025 filings availableOrigio India Private Limited reported revenue of ₹213.52 Cr (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 5% growth in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Origio India Private Limited, buy the company report.
Board of directors of Origio India Private Limited
Origio India has 7 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shipra Thukral | Director | 22 Jun 2023 | 3 Years 4 Months | Current |
| Amit Kumar Bhatnagar | Director | 01 Sep 2016 | 10 Years 2 Months | Current |
| Agostino Ricupati Also directs: Cvi Contact Lens India Private Limited | Director | 03 Sep 2021 | 5 Years 2 Months | Current |
| Brian George Andrews | Director | 03 Sep 2021 | 5 Years 2 Months | Current |
| John Joseph Calcagno | Director | 29 Sep 2021 | 5 Years 1 Months | Current |
| Nigel Anton Penfold | Director | 14 Jul 2025 | 1 Years 3 Months | Current |
Peer comparison
Origio India Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avana Medical Devices Private Limited | ₹223.27 Cr (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Vasu Vaccines and Speciality Drugs Hyd Private Limited | ₹215.31 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Shreeji Distributors Pharma Private Limited | ₹214.34 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Origio India Private Limitedthis company | ₹213.52 Cr (FY 2025) | ₹8.65 Cr | 4.1% | 5.0% | 84 | Mumbai, Maharashtra, India |
| Ceragem India Private Limited | ₹205.91 Cr (FY 2025) | 2.0% | Dehradun, Uttarakhand, India | |||
| Umang Cure Private Limited | ₹203.3 Cr (FY 2025) | 14.0% | New Delhi, Delhi, India | |||
| Concept Medical Research Private Limited | ₹198.16 Cr (FY 2025) | 58.0% | Surat, Gujarat, India |
To see the full peer comparison of Origio India Private Limited, buy the company report.
Auditor
Origio India Private Limited is audited by A. N. KOTHARI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A. N. KOTHARI & CO. | FY 2023 | 112807W |
Shareholding
The shareholding of Origio India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Origio India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jul 2009 | 10173069 | The Saraswat Co-Operative Bank Limited | ₹1.5 Cr | Satisfied | |
| 10 Jul 2009 | 10173070 | The Saraswat Co-Operative Bank Limited | ₹3 Cr | Satisfied |
To see the full charge records of Origio India Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Origio India Private Limited has 7 deals on record (4 rights issues, 3 secondary share transfers); the latest was in October 2023.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2023 | Rights issue | ₹18.28 Cr | Investors: an individual |
| Apr 2020 | Rights issue | ₹9.99 Cr | Investors: an individual |
| Jan 2018 | Rights issue | ₹9.11 Cr | Investors: an individual |
| Aug 2015 | Rights issue | ₹1.63 Cr | Investors: an individual |
| Feb 2015 | Secondary share transfer | Undisclosed | Buyer: Origio Limited, an individual Seller: 2 individuals |
To see the full deal history of Origio India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Origio India Private Limited has 3 court cases on record: 2 filed by Origio India, 1 filed against it. 2 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed by the company against individuals | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed by the company against M/S Kanak Overseas and 1 other | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS Cases) | Filed against the company by S Ward Shop and Establishment Department (Through Prashant Tukaram Bendhari) | Disposed |
To see the full case history of Origio India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Origio India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Origio India Private Limited has a workforce of 84 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Origio India has 15 GST registrations: 5 active and 10 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCT3478Q1ZK | Maharashtra | Active | 01 Jul 2017 |
| 06AACCT3478Q1ZO | Haryana | Active | 01 Jul 2017 |
| 19AACCT3478Q1ZH | West Bengal | Active | 01 Jul 2017 |
| 24AACCT3478Q1ZQ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Origio India Private Limited, buy the company report.
Recent activity
Origio India Private Limited has 23 board changes on record since 2014: 7 appointments and 16 cessations. The latest: Nigel Anton Penfold ceased to be Additional Director on 28 Sep 2025.
18 earlier events are in the company report.
News
Frequently asked questions
Origio India is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 03 August 2005 (21+ years old) and is registered under CIN U24230MH2005PTC155098.
Origio India has 7 current directors:
- Shipra Thukral - Director
- Amit Kumar Bhatnagar - Director
- Agostino Ricupati - Director
- Brian George Andrews - Director
- John Joseph Calcagno - Director
- Nigel Anton Penfold - Director
- Suchit Pravinchandra Shah - Director
The latest financial statements of Origio India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Origio India is 27AACCT3478Q1ZK, registered in Maharashtra. The company has 15 GST registrations in all, of which 5 are active and 10 are cancelled or inactive. Other active GSTINs include 06AACCT3478Q1ZO (Haryana), 19AACCT3478Q1ZH (West Bengal), 24AACCT3478Q1ZQ (Gujarat).
The CIN (Corporate Identification Number) of Origio India is U24230MH2005PTC155098. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Origio India has 3 court cases on record: 2 filed by the company and 1 filed against it. 2 are pending.
Origio India was incorporated on 03 August 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Origio India has 7 deals on record (4 rights issues, 3 secondary share transfers); the latest was in October 2023.
The peers of Origio India by revenue are Avana Medical Devices Private Limited, Vasu Vaccines and Speciality Drugs Hyd Private Limited, Shreeji Distributors Pharma Private Limited, Ceragem India Private Limited, Umang Cure Private Limited and 1 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Nigel Anton Penfold ceased to be Additional Director on 28 Sep 2025. Nigel Anton Penfold was appointed as Director on 14 Jul 2025. John Joseph Calcagno ceased to be Director on 15 Apr 2025. Origio India has 23 board changes on record in total.
Origio India can be reached through the website coopersurgical.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
